Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Class A Common Stock, $0.00001 par value per share
-
Shares outstanding
-
4,564,846
-
Total 13F shares
-
46,974,230
-
Share change
-
+46,974,200
-
Total reported value
-
$1,714,334,294
-
Price per share
-
$36.50
-
Number of holders
-
75
-
Value change
-
+$1,714,333,294
-
Number of buys
-
74
Institutional Holders of RECURSION PHARMACEUTICALS, INC. - Class A Common Stock, $0.00001 par value per share (RXRX) as of Q2 2021
As of 30 Jun 2021 RECURSION PHARMACEUTICALS, INC. - Class A Common Stock, $0.00001 par value per share (RXRX) had 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 46,974,230 shares of stock of the company.
Largest 10 holders included BAILLIE GIFFORD & CO, Laurion Capital Management LP, VANGUARD GROUP INC, ARK Investment Management LLC, FMR LLC, HARVARD MANAGEMENT CO INC, CREDIT SUISSE AG/, BlackRock Inc., MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC, and ALLIANCEBERNSTEIN L.P..
This table shows 75 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.